Kathrin Koch

Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers

U. Dietrich, I. Wilson, A. Ward, 2017, Scientific Reports.

Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?

U. Dietrich, B. Müller, Z. Zeng, 2020, Vaccines.

Low expression of thiosulfate sulfurtransferase (rhodanese) predicts mortality in hemodialysis patients.

M. Tepel, A. Scholze, Kathrin Koch, 2010, Clinical biochemistry.

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

K. Döhner, H. Döhner, V. Gaidzik, 2021, Blood Cancer Journal.

CNS Pericytes Modulate Local T Cell Infiltration in EAE

H. Wiendl, T. Kuhlmann, A. Zarbock, 2022, International journal of molecular sciences.

P-D1 Selection and characterization of neutralizing nanobodies from dromedaries immunized with soluble trimeric HIV-1 Env SOSIP proteins

U. Dietrich, U. Wernery, F. Koch-Nolte, 2016 .

Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity

H. Wiendl, T. Kuhlmann, M. Beyer, 2018, Proceedings of the National Academy of Sciences.

Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity

D. Schuppan, P. Rosenstiel, H. Wiendl, 2021, Brain : a journal of neurology.

Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound

H. Wiendl, D. Schafflick, A. Schulte-Mecklenbeck, 2022, Proceedings of the National Academy of Sciences of the United States of America.